Edwardsiella tarda is a pathogen with a broad host range infecting animals and humans. We have reported recently that the type III secretion system (TTSS) is essential for intracellular replication of the bacterium in murine macrophages. The present study shows that the TTSS is also needed for intracellular growth of the bacterium in human epithelial cells (HEp-2). However, different from the previous microarray analyses on murine macrophages, upregulation of the mRNA expression level of NF-kB target genes was not detected in the infected HEp-2 cells. The wild-type E. tarda, but not its TTSS mutant, actually repressed the tumor necrosis factor a-dependent NF-kB activation in an NF-kB reporter gene assay. These results suggest TTSS-dependent repression of the NF-kB activation in HEp-2 cells infected with E. tarda.
Introduction
Edwardsiella tarda, a member of the family Enterobacteriaceae, causes edwardsiellosis in several species of cultured freshwater and marine fish (Plumb, 1999; Muroga, 2001) . The bacterium has also been isolated from various kinds of animals, including humans (Sakazaki, 2001) . Although the pathogenicity of E. tarda is still largely unknown, some virulence factors related to the pathogenicity of this organism have been reported including the ability to invade and replicate within epithelial cells, to resist phagocyte-mediated killing (Ainsworth & Chen, 1990; Iida & Wakabayashi, 1993; Okuda et al., 2006) , and to produce toxins such as dermatotoxins (Ullah & Arai, 1983) and hemolysins (Hirono et al., 1997; Strauss et al., 1997) . Among the virulence factors, the ability to invade and replicate within epithelial cells such as HeLa (Marques et al., 1984) and HEp-2 (Janda et al., 1991; Strauss et al., 1997) appears to play an important role in E. tarda infection because the well-known clinical symptoms caused by its infection include bacteremia and bloody colitis, suggesting that E. tarda can invade and replicate within epithelial cells to spread systemically and cause tissue damage.
Many Gram-negative pathogenic bacteria secrete virulence factors via a conserved protein secretion machinery termed the 'type III secretion system' (TTSS) and cause disease. The TTSS apparatus consists of c. 20-25 proteins and the unique feature of the TTSS is a needle-like structure where proteins are injected into host cells. These proteins are termed effectors and play key roles in the pathogenic relationship between the host and bacteria. The TTSS in E. tarda was reported to be similar to that encoded by the Salmonella SPI2 (Srinivasa Rao et al., 2003; Tan et al., 2005) . We have reported recently that the TTSS of E. tarda is required for the intracellular accumulation of this bacterium in murine macrophages similar to Salmonella (Okuda et al., 2006) . This suggests that the TTSS of E. tarda functions to deliver effectors into macrophages to survive in the host cells.
In this study, TTSS is shown to be required for the intracellular accumulation of E. tarda in epithelial cells . Further, we demonstrate that the responsiveness of NF-kB in HEp-2 cells infected with E. tarda is different from that in murine macrophages.
Materials and methods

Bacterial strains, bacterial growth and media
The wild-type strain (FK1051) of E. tarda, which was isolated from a diseased Japanese flounder Paralichthys olivaceus, was used in this study. A TTSS-deficient mutant (mET1229) was constructed as described previously (Okuda et al., 2006) by a knockout of the wild-type esaV gene reported to be a Yersinia enterocolitica yscV homolog (Tan et al., 2005) . Bacteria were grown in Tripto-Soy broth (TSB, Eiken) at 30 1C. TSB supplemented with kanamycin (50 mg mL À1 ) was used for mET1229.
HEp-2 cells
HEp-2 cells, a carcinoma human larynx cell line, were obtained from Dainippon Pharmaceutical Co. Ltd (Osaka, Japan) and maintained in DMEM (Sigma) supplemented with 10% FCS. 
Microarray analysis
Total RNA of HEp-2 cells was obtained from three independent experiments using six-well tissue culture plates at 5 or 22 h after infection with E. tarda as described above. For microarray analysis, the total RNAs were used for antisense amino allyl RNA (aRNA) synthesis and for hybridization to the AceGene Human Oligo Chip 30K (Hitachi), on which 30 000 human genes were printed, according to the manufacturer's instructions. RNA amplification and labeling were performed using an Amino Allyl MessageAmp TM aRNA Kit (Ambion) following the manufacturer's protocol. Doublestranded cDNAs were synthesized from 1 mg of total RNAs using T7 oligo(dT) primer. Using these double-stranded cDNAs as templates, aRNA was then generated with 5-(3-aminoallyl)-UTP (aaUTP). After purification of the aRNA, a dye coupling reaction between the amino allyl-modified UTP residues on the aRNA and amine reactive dyes [Cy3-and Cy5-monoreactive dyes (Amersham)] was carried out. The Cy3-and Cy5-labeled aRNAs were purified using the microbio-spin column P30 (BioRad) and were fragmented. The AceGene Human Oligo Chips were then hybridized with the fragmented Cy3-and Cy5-labeled aRNAs at 42 1C for 17 h. After hybridization, the oligo chips were washed with 2 Â standard saline citrate (SSC; 0.3 M NaCl, 0.3 M Na-citrate) and 0.1% sodium dodecyl sulfate for 5 min at 30 1C, rinsed with 2 Â SSC and 1 Â SSC, and finally dried. The fluorescent signal was detected using a microarray scanner (ScanArray Lite, PerkinElmer).
The fluorescent intensities on a scan image were quantified, corrected for backgroud noise, and normalized with the software DNASIS Array (Hitachi Software Engineering) as described previously (Okuda et al., 2006) . In brief, data either from control spots or from spots containing high intensities of artificial signals were removed. The signal intensity of each spot was then normalized to equalize the total signal intensity. The normalized signal intensity of each spot was plotted on a scatter plot with the Cy3 fluorescence on the x-axis and Cy5 fluorescence on the y-axis (data not shown). The ratio of Cy5 fluorescence (gene expression in HEp-2 cells infected with the wild-type strain) to Cy3 fluorescence (gene expression in HEp-2 cells infected with the mET1229) was calculated and genes with an outstanding Cy5 : Cy3 ratio (Cy5-wild : Cy3-mET1229 ratio) 42.0 or o 0.5 were listed.
NF-jB reporter gene assay
Plasmid p55IgkLuc carrying the three NF-kB DNA-binding sites that drive the expression of the luciferase gene was described previously (Okuda et al., 2006) . The pRL-CMV vector carrying the CMV-driven renilla-luciferase reporter gene was used as an internal control reporter and was purchased from Promega. HEp-2 cells (2 Â 10 5 ) grown in six-well plates for 24 h were cotransfected with 1580 ng of the reporter plasmid p55IgkLuc and 340 ng of the control plasmid pRL-CMV using FuGENE 6 Transfection Reagent (Roche), followed by incubation for 18 h. The transfected cells were infected with the wild-type E. tarda and mET1229 at a MOI of one for 30 min before prewarmed tissue culture medium containing 200 mg mL À1 gentamicin was added.
After a 1.5-h incubation, the medium was removed, washed twice with PBS, and tissue culture medium without gentamicin was added, followed by addition of 10 ng mL À1 tumor necrosis factor (TNF) a or its mock buffer. The HEp-2 cells were incubated for 12 h at 37 1C under 5% CO 2 . At 12 h after infection, cells were washed with PBS and lysed in 500 mL of cell lysis buffer. Luciferase activity in the cell lysate was assayed using the Dual-Luciferase Reporter Assay System (Promega). The relative NF-kB-luciferase activity was defined as the mean AE SD Â 10 À3 (n = 3) of the activity ratio of luciferase compared with renilla-luciferase. Statistical analysis was performed using a two-tailed t-test. TNFa was purchased from PeproTech EC.
Results and discussion
Intracellular replication of E. tarda in HEp-2 cells
We compared the level of intracellular replication of the wild-type E. tarda and type III mutant, mET1229, in HEp-2 cells at a MOI of one. The number of viable cells increased for the wild-type from 5 to 22 h after infection, whereas mET1229 decreased and most of the mET1229 were sacrificed by 22 h (Fig. 1) . This suggests that the TTSS is required for intracellular survival of E. tarda in epithelial cells as well as in murine macrophages (Okuda et al., 2006) .
Microarray analysis on HEp -2 cells
To compare the mRNA expression levels in HEp-2 cells infected with the wild type with those infected with mET1229 at a MOI of one, we carried out microarray analysis on HEp-2 cells, where 30 000 human genes were analyzed. At 5 and 22 h after infection, the total RNAs were Ã For each time point after infection, results are shown in order of decreasing fold increase of (wild/mutant) ratio.
For the 5 h time point, the 15 highest increases are shown.
For the 22 h time point, only five increases are detected.
Type III secretion system-dependent repression of NF-kB activation extracted from the HEp-2 cells infected with the wild type or mET1229. The relative mRNA expression levels in the wild-type-infected vs. mET1229-infected cells varied from 2.71-to 0.14-fold at 5 h, and 2.54-to 0.045-fold at 22 h after infection. The majority of the genes (99.6% and 98.8%, respectively, at 5 and 22 h) exhibited little change in mRNA expression levels (between 2 and 0.5, data not shown). Among the up regulated genes (77 and five genes, respectively, at 5 and 22 h), most genes exhibited poorly understood cellular functions (Table 1) . In addition, among the down regulated genes (51 and 368 genes, respectively, at 5 and 22 h), the majority of the genes showed poorly understood cellular functions as well (Table 2) . Previously, we reported that in murine macrophages infected with the wild type, up regulation of many known NF-kB target genes associated with inflammation and antiapoptosis was detected (Okuda et al., 2006) . However, different from our previous observations in macrophages, the present microarray analysis showed that up regulation of the mRNA expression level of NF-kB target genes (e.g. proinflammatory cytokines and antiapoptotic genes) was not detected in HEp-2 cells infected with the wild-type strain. Here, we hypothesized that infection of HEp-2 cells with the wild-type strain does not cause NF-kB activation in spite of the fact that a large number of the wildtype strains are present in HEp-2 cells. To confirm this hypothesis, we next investigated whether infection of HEp-2 cells with the wild-type strain will not actually induce NF-kB activity by an NF-kB reporter gene assay.
NF-jB reporter gene assay
On the basis of the microarray data, it was strongly suggested that intracellular replication of the wild type in HEp-2 cells does not induce NF-kB activation. To show this NF-kB irresponsiveness to intracellular replication of the wild type in HEp-2 cells, we performed an NF-kB reporter gene assay (Fig. 2) . NF-kB activity increased as the cells were treated with TNFa for 12 h without infection (positive control). On the contrary, infection of HEp-2 cells for 12 h with the wild type at a MOI of one did not trigger NF-kB activation as well as infection with the mET1229, although a vast number of the wild-type E. tarda is present within HEp-2 cells at 12 h after infection (Fig. 1) . Furthermore, we investigated whether the wild-type strain represses NF-kB activation induced by TNFa dependent on the TTSS. As shown in Fig. 2 , the wild-type strain, but not the TTSS-negative mutant, significantly reduced the NF-kB activation induced by TNFa (P o 0.005 for between treatment with only TNFa and TNFa-treated wild-type infection; P o 0.001 for between TNFa-treated wild-type infection and TNFa-treated TTSS-negative mutant infection).
It is well known that the YopJ family of the type III effector proteins secreted by pathogenic Yersinia species prevents the activation of the superfamily of mitogenactivated protein kinase (MAPK) kinases, which include the IkB kinase (IKK) complex (Girardin et al., 2002) . As a result of interference with IKK complex, signaling through the NF-kB pathway is prevented, resulting in blockage of cytokine secretion and promotion of apoptosis in the host cells. Recently, AopP, a type III effector protein of the species Aeromonas salmonicida which is included among the aeromonad fish pathogens, has been reported to inhibit the NF-kB singalling pathway (Orth, 2002) . While AopP showed sequence homology with YopJ, AopP exhibited different inhibitory activitiy from YopJ, i.e., AopP inhibited the NF-kB signaling pathway at a point downstream of IKK but did not affect MAPK signaling. In this study, we observed that intracellular replication of E. tarda in HEp-2 cells does not induce up regulation of NF-kB activity, which may suggest the presence of an unidentified type III effector in E. tarda that inhibits the NF-kB signaling pathway like YopJ and AopP. Suppression of NF-kB activity will be important for replication of E. tarda in HEp-2 cells by blocking cytokine production and inducing host cell apoptotic response. Further investigations are in progress to identify the new type III effector in E. tarda that may modulate NF-kB sinaling pathway.
Salmonella possesses two kinds of TTSS called TTSS-1 and TTSS-2. TTSS-1, encoded by Salmonella pathogenicity island 1 (SPI1), secretes effectors into the target epithelial cells from outside of the cell (Fehr et al., 2006) . On the other hand, TTSS-2 encoded by Salmonella pathogenicity island 2 (SPI2) injects effectors into the target phagocytes from inside of the phagosome (Fehr et al., 2006) . To date, in E. tarda, only a kind of TTSS, which is homologous to the Salmonella TTSS-2, is found. In this study, as a type III mutant of E. tarda did not replicate in HEp-2 cells as well as J774 macrophages (Okuda et al., 2006) , it is suspected that only one TTSS is present in E. tarda and it plays an important role in infection of the bacterium to both macrophages and epithelial cells. Fig. 2 . TTSS-dependent suppression of TNFa-induced NF-kB activity by the intracellular growth of the wild-type Edwardsiella tarda in HEp-2 cells. The relative NF-kB-luciferase activity in HEp-2 cells after infection with the wild-type and mET1229 or without infection was determined in the presence or in the absence of TNFa as described in 'Materials and methods'. Relative NF-kB-luciferase activity was defined as the mean AE SD Â 10 À3 (n = 3) of the activity ratio of luciferase compared with renilla-luciferase. HEp-2 cells infected with the wild-type E. tarda or mET1229 at a MOI of one were treated with mock buffer (samples #2 and 3) or 10 ng mL À1 TNFa (samples #5 and 6). Treatment of HEp-2 cells with only TNFa (sample #4) was a positive control for NF-kB activity induction and 'no treatment' represents the background level (sample #1).
The differences between treatment with only TNFa and TNFa-treated wildtype infection (samples #4 and #5) and TNFa-treated wild-type infection and TNFa-treated mET1229 infection (samples #5 and #6) were found to be significant at P o 0.005 and o 0.001, respectively. Abbreviations: W1, wildtype infection at a MOI of one; M1, mET1229 infection at a MOI of one.
